Quick Answer
ACADIA PHARMACEUTICALS INC reported Earnings Per Share Diluted of $2.30 per share for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +69.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.42 (loss) per share | Q2 2021: $0.27 (loss) per share | Q3 2021: $0.09 (loss) per share | Q4 2021: $0.27 (loss) per share | Q1 2022: $0.70 (loss) per share | Q2 2022: $0.21 (loss) per share | Q3 2022: $0.17 (loss) per share | Q4 2022: $0.26 (loss) per share | Q1 2023: $0.27 (loss) per share | Q2 2023: $0.01 per share | Q3 2023: $0.40 (loss) per share | Q4 2023: $0.28 per share | Q1 2024: $0.10 per share | Q2 2024: $0.20 per share | Q3 2024: $0.20 per share | Q1 2025: $0.11 per share | Q2 2025: $0.16 per share | Q3 2025: $0.42 per share.
- Over the full 10 years of available data (2009 to 2025), ACADIA PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 291.7%.
- Historical annual values: Fiscal year 2025: $2.30 per share | Fiscal year 2024: $1.36 per share | Fiscal year 2023: $0.37 (loss) per share | Fiscal year 2022: $1.34 (loss) per share | Fiscal year 2021: $1.05 (loss) per share | Fiscal year 2020: $1.79 (loss) per share | Fiscal year 2012: $0.38 (loss) per share | Fiscal year 2011: $0.44 (loss) per share | Fiscal year 2010: $0.39 per share | Fiscal year 2009: $1.20 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: